Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 5, 2011, Pages 338-345

  Lee, Yi Chien ^a   Wang, Jann Tay ^b   Sun, Hsin Yun ^b   Chen, Yee Chun ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Charlson comorbidity score; Cryptococcal meningitis; HIV

Indexed keywords

AMPHOTERICIN B; PROTEIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMORBIDITY; COUGHING; CRYPTOCOCCAL MENINGITIS; FEMALE; HEADACHE; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; MUSCLE WEAKNESS; SPEECH DISORDER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CRYPTOCOCCUS NEOFORMANS; FEMALE; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TAIWAN;

EID: 80053645911     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2010.08.011     Document Type: Article

References (31)

1. Holmes C.B., Losina E., Walensky R.P., Yazdanpanah Y., Freedberg K. Review of human immunodeficiency virus type 1-related opportunistic infections in Sub-Saharan Africa. Clin Infect Dis 2003, 36:652-662.
2. Chariyalertsak S., Sirisanthana T., Saengwonloey O., Nelson K. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin Infect Dis 2001, 32:955-962.
3. Mitchell T.G., Perfect J.R. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548.
4. Pappas P.G., Perfect J.R., Cloud G.A., Larsen R.A., Pankey G.A., Lancaster D.J., et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001, 33:690-698.
5. Ennis D.M., Saag M.S. Cryptococcal meningitis in AIDS. Hosp Pract 1993, 28:99-112.
6. Powderly W.G. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993, 17:837-842.
7. Sun H.Y., Chen M.Y., Hsiao C.F., Hsieh S.M., Hung C.C., Chang S.C. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clin Microbiol Infect 2006, 12:381-388.
8. Saag M.S., Graybill R.J., Larsen R.A., Pappas P.G., Perfect J.R., Powderly W.G., et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:710-718.
9. Yu Y.L., Lau Y.N., Woo E., Wong K.L., Tse B. Cryptococcal infection of the nervous system. Q J Med 1988, 66:87-96.
10. Shih C.C., Chen Y.C., Chang S.C., Luh K.T., Hsieh W.C. Cryptococcal meningitis in non-HIV-infected patients. Q J Med 2000, 93:245-251.
11. Rozenbaum R., Goncalves A.J.R. Clinical epidemiological study of 171 cases of cryptococcosis. Clin I Dis 1994, 18:369-380.
12. Richardson P.M., Mohandas A., Arumugasamy N. Cerebral cryptococcosis in Malaysia. J Neurol Neurosurg Psychiatry 1976, 39:330-337.
13. Diamond R.D., Bennett J.E. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974, 80:176-181.
14. Dromer F., Mathoulin S., Dupont B., Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin Infect Dis 1996, 23:82-90. and the French Cryptococcosis Study Group.
15. Moosa M.Y.S., Coovadia Y.M. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. Clin Infect Dis 1997, 24:131-134.
16. Chuck S.L., Sande M.A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989, 321:794-799.
17. Dismukes W.E. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988, 157:624-628.
18. Clark R.A., Greer D., Atkinson W., Valainis D.T., Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990, 12:768-777.
19. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007, 4:e21. the French Cryptococcosis Study Group.
20. Lortholary O., Poizat G., Zeller V., Neuville S., Boibieux A., Alvarez M., et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006, 20:2183-2191.
21. Lu C.H., Chang W.N., Chang H.W., Chuang Y.C. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999, 42:313-320.
22. Kiertiburanakul S., Wirojtananugoon S., Pracharktam R., Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 2006, 10:72-78.
23. Dismukes W.E., Cloud G., Gallis H.A., Kerkering T.M., Medoff G., Carven P.C., et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987, 317:334-341.
24. Saag M.S., Powderly W.G., Cloud G.A., Robinson P., Grieco M.H., Sharkey P.K., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992, 326:83-89.
25. Zuger A., Louie E., Holzman R.S., Simberkoff M.S., Rahal J.J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986, 104:234-240.
26. Richardson P.M., Mohandas A., Arumugasamy N. Cerebral cryptococcosis in Malaysia. J Neurol Neurosurg Psychiatry 1976, 39:330-337.
27. Bicanic T., Harrison T.S. Cryptococcal meningitis. Br Med Bull 2005, 72:99-118.
28. Jean S.S., Fang C.T., Shau W.Y., Chen Y.C., Chang S.C., Hsueh P.R., et al. Cryptococcaemia: clinical features and prognostic factors. Q J Med 2002, 95:511-518.
29. Ganiem A.R., Parwati I., Wisaksana R., van der Zanden A., van de Beek D., Sturm P., et al. The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study. AIDS 2009, 23:2309-2316.
30. Sun H.Y., Hung C.C., Chang S.C. Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis 2004, 38:1790-1792.
31. Perfect J.R., Dismukes W.E., Dromer F., Goldman D.L., Graybill J.R., Hamill R.J., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:291-322.